[1] MA AJ, ZHAO YL.The prevalence and surveillance of drug-resistant tuberculosis[J]. Chinese Journal of Antibiotics(中国抗生素杂志), 2018, 43(5): 502-506. [2] GAO R, LIANG JF, LU Q, et al.Epidemiological characteristics of tuberculosis in mainland China from 2004 to 2015[J]. Modern Preventive Medicine(现代预防医学), 2018, 45(14): 2501-2509. [3] LIU FF, CHEN YK.Research progress of liver injury induced by anti-tuberculosis drugs[J]. Chongqing Medicine(重庆医学), 2014, 43(19): 2512-2514. [4] LI HY, YANG CP, JIN HT.Research progress on the mechanism of liver injury induced by commonly used drugs[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(12): 750-756. [5] ZHOU YJ, LU JM.Timeliness of hepatotoxicity induced by pyrazinamide in rats[J]. Zhejiang Journal of Integrated traditional Chinese and Western Medicine(浙江中西医结合杂志), 2005, 5(10): 612-613. [6] ZHA YF, ZHANG GY, LI ZH, et al.Relationship between lipid peroxidation and antitubercular drugs-induced liver injuries[J]. Hebei Medical Journal(河北医药), 2004, 26(9): 689-691. [7] IASELLA CJ, JOHNSON HJ, DUNN MA.Adverse drug reactions: type A (Intrinsic) or type B (Idiosyncratic)[J]. Clin Liver Dis, 2017, 21(1): 73-87. [8] LI W, ZHONG HL, WEN XZ, et al.The Prevention and treatment of anti-TB drug induced liver injuries: a literature review[J]. Modern Hospital(现代医院), 2015, 15(9): 9-12. [9] IRUZUBIETA P, ARIAS-LOSTE MT, BARBIER-TORRES L, et al.The Need for biomarkers in diagnosis and prognosis of drug-induced liver disease: does metabolomics have any role?[J]. Biomed Research International, 2015, 2015: 386186. [10] RAWAT A, CHATURVEDI S, SINGH AK, et al.Metabolomics approach discriminates toxicity index of pyrazinamide and its metabolic products, pyrazinoic acid and 5-hydroxy pyrazinoic acid[J]. Human & Experimental Toxicology, 2018, 37(4): 373-389. [11] SHIH TY, PAI CY, YANG P, et al.A novel mechanism underlies the hepatotoxicity of pyrazinamide[J]. Antimicrob Agents Chemother, 2013, 57(4): 1684-1690. [12] ZHANG Y, GUO HL, ZHANG LY, et al.Research progress in pyrazinamide-induced hepatotoxicity[J]. Drug Evaluation Research(药物评价研究), 2014, 37(6): 558-560. [13] LIU B, DING P, FENG GQ.Research progress in antituberculosis drugs-induced liver injury[J]. Strait Pharmaceutical(海峡药学), 2016, 28(3): 5-9. [14] ZHOU YC, LIU B.Reaserch progress of anti-tuberculosis drugs induced hepatotoxicity[J]. Journal of International Pathology and Clinical Medicine, 2011, 31(4): 362. [15] WU N, CAI GM, HE Q.Oxidative stress and hepatic injury[J]. World Journal of Chinese Digestion(世界华人消化杂志), 2008, 16(29): 3310-3315. [16] YU YH.Study on the mechanism of P62/Nrf2 signal pathway in alcohol-induced injury of liver L02 cells[D]. Kaifeng: Henan University, 2019. [17] BIRBEN E, SAHINER UM, Sackesen C, et al.Oxidative stress and antioxidant defense[J]. World Allergy Organization Journal, 2012, 5(1): 9-19. [18] ZHANG QZ. Molecular Pharmacology(分子药理学)[M]. Beijing: Higher Education Press, 2007. [19] RAY PD, HUANG BW, TSUJI Y.Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling[J]. Cell Signal, 2012, 24(5): 981-990. [20] VALENCIA AM, ABRANTES MA, HASAN J, et al.Reactive oxygen species, biomarkers of microvascular maturation and alveolarization, and antioxidants in oxidative lung injury[J]. React Oxyg Species (Apex), 2018, 6(18): 373-388. [21] XU Y, GAO W, ZHANG Y, et al.ABT737 reverses cisplatin resist-ance by targeting glucose metabolism of human ovarian cancer cells[J]. Int J Oncol, 2018, 53(3): 1055-1068. [22] QI S, FENG Z, LI Q, et al.Inhibition of ROS-mediated activation Src-MAPK/AKT signaling by orientin alleviates H2O2-induced apoptosis in PC12 cells[J]. Drug Des Devel Ther, 2018, 16(12): 3973-3984. [23] KNOBEL B, BUYANOWSKY G, DAN M, et al.Pyrazinamide-induced granulomatous hepatitis[J]. J Clin Gastroenterol, 1997, 24(4): 264-266. |